Insights from DCE-MRI: blood-brain barrier permeability in the context of MS relapses and methylprednisolone treatment.

Cramer SP, Hamrouni N, Simonsen HJ, Vestergaard MB, Varatharaj A, Galea I, Lindberg U, Frederiksen JL, Larsson HBW.

Open source

DOI
10.3389/fnins.2025.1546236
Published
2025-03-20
Container
Front Neurosci
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fnins.2025.1546236,
  title = {Insights from DCE-MRI: blood-brain barrier permeability in the context of MS relapses and methylprednisolone treatment.},
  author = {Cramer SP and  Hamrouni N and  Simonsen HJ and  Vestergaard MB and  Varatharaj A and  Galea I and  Lindberg U and  Frederiksen JL and  Larsson HBW.},
  year = {2025},
  journal = {Front Neurosci},
  doi = {10.3389/fnins.2025.1546236},
  url = {https://doi.org/10.3389/fnins.2025.1546236}
}

RIS

TY  - JOUR
TI  - Insights from DCE-MRI: blood-brain barrier permeability in the context of MS relapses and methylprednisolone treatment.
AU  - Cramer SP
AU  -  Hamrouni N
AU  -  Simonsen HJ
AU  -  Vestergaard MB
AU  -  Varatharaj A
AU  -  Galea I
AU  -  Lindberg U
AU  -  Frederiksen JL
AU  -  Larsson HBW.
PY  - 2025
JO  - Front Neurosci
DO  - 10.3389/fnins.2025.1546236
UR  - https://doi.org/10.3389/fnins.2025.1546236
ER  - 

APA

SP, C., N, H., HJ, S., MB, V., A, V., I, G., U, L., JL, F., & HBW., L. (2025). Insights from DCE-MRI: blood-brain barrier permeability in the context of MS relapses and methylprednisolone treatment.. Front Neurosci. https://doi.org/10.3389/fnins.2025.1546236

Source records